# Virtual Screening ML

## Overview
Virtual Screening using Machine Learning (ML) focuses on using algorithms to predict potential drug candidates based on diverse chemical structures. This approach enhances the efficiency and accuracy of the drug discovery process, allowing researchers to swiftly identify compounds with the highest likelihood of biological activity.

## Process
1. **Data Preparation**: Gather and clean data sets of known compounds and their biological activity.
2. **Feature Selection**: Identify relevant features that influence biological activity using techniques such as PCA or LASSO.
3. **Model Training**: Utilize machine learning models (e.g., Random Forest, SVM, Neural Networks) to train on prepared datasets.
4. **Prediction**: Apply the trained model to screen large libraries of compounds to find those likely to succeed in biological testing.
5. **Validation**: Experimental validation of shortlisted candidates to confirm efficacy.

## Tools & Libraries
- Scikit-learn
- TensorFlow/Keras
- RDKit
- Open Babel

## Conclusion
The implementation of ML in Virtual Screening promises to revolutionize medicinal chemistry by significantly reducing the time and resources needed to bring drugs to market.